tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Morena M et al. Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients. 2000 Transplant. Proc. pmid:11134805
Fischer S et al. Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. 2000 Transplant. Proc. pmid:11134815
Sam WJ et al. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. 2000 Br J Clin Pharmacol pmid:11136292
Sestak K et al. Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. 2000 Vet. Immunol. Immunopathol. pmid:11137126
Michnick SW Chemical biology beyond binary codes. 2000 Chem. Biol. pmid:11137822
Lopau K et al. Tacrolimus in acute renal failure: does L-arginine-infusion prevent changes in renal hemodynamics? 2000 Transpl. Int. pmid:11140242
Abraham KA et al. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus. 2000 Transpl. Int. pmid:11140243
Haas M et al. Hypothyroidism as a cause of tacrolimus intoxication and acute renal failure: a case report. 2000 Wien. Klin. Wochenschr. pmid:11144010
Barone GW et al. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria. 2001 J Clin Pharmacol pmid:11144989
Bekersky I et al. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. 2001 J. Am. Acad. Dermatol. pmid:11145792
Hanifin JM et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. 2001 J. Am. Acad. Dermatol. pmid:11145793
Soter NA et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. 2001 J. Am. Acad. Dermatol. pmid:11145794
Paller A et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. 2001 J. Am. Acad. Dermatol. pmid:11145795
Kang S et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. 2001 J. Am. Acad. Dermatol. pmid:11145796
Drake L et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. 2001 J. Am. Acad. Dermatol. pmid:11145797
Vallejo C et al. Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus. 2001 Haematologica pmid:11146586
Nghiem P "Topical immunomodulators?": introducing old friends and a new ally, tacrolimus. 2001 J. Am. Acad. Dermatol. pmid:11148486
Butani L and Makker SP Conversion from tacrolimus to neoral for postrenal transplant diabetes. 2000 Pediatr. Nephrol. pmid:11149106
Gondo H et al. Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation. 2000 Bone Marrow Transplant. pmid:11149744
Remitz A et al. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. 2001 J. Allergy Clin. Immunol. pmid:11150013
Emre S et al. Safety and risk of using pediatric donor livers in adult liver transplantation. 2001 Liver Transpl. pmid:11150421
Nagatomo I et al. Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice. 2001 Brain Res. pmid:11150489
Hamar P et al. Interleukin-2-dependent mechanisms are involved in the development of glomerulosclerosis after partial renal ablation in rats. 2001 Mar-Apr Exp. Nephrol. pmid:11150862
Bain JR Peripheral nerve and neuromuscular allotransplantation: current status. 2000 Microsurgery pmid:11150988
Gruber SA et al. Local drug delivery to composite tissue allografts. 2000 Microsurgery pmid:11150992
König A et al. Intravascular ultrasound for assessment of coronary allograft vasculopathy. 2000 Z Kardiol pmid:11151792
Kainz A et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. 2000 Transplantation pmid:11152103
MacDonald AS Impact of immunosuppressive therapy on hypertension. 2000 Transplantation pmid:11152235
Cather JC et al. Cyclosporine and tacrolimus in dermatology. 2001 Dermatol Clin pmid:11155577
Tolou-Ghamari Z et al. In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation. 2000 Clin. Chem. Lab. Med. pmid:11156362
Mathis AS and Friedman GS Coadministration of digoxin with itraconazole in renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11157404
Prestle J et al. Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. 2001 Circ. Res. pmid:11157671
Ligtenberg G et al. Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. 2001 J. Am. Soc. Nephrol. pmid:11158228
Coupes BM et al. Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients. 2001 Nephrol. Dial. Transplant. pmid:11158413
Hanauer SB and Dassopoulos T Evolving treatment strategies for inflammatory bowel disease. 2001 Annu. Rev. Med. pmid:11160781
Rose N and Lever A The rapamycin sensitivity of human T-cell leukaemia virus type I-induced T-cell proliferation is mediated independently of the polypyrimidine motifs in the 5' long terminal repeat. 2001 J. Gen. Virol. pmid:11161283
Peeling J et al. Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat. 2001 Exp. Neurol. pmid:11161622
Hofbauer LC et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. 2001 Biochem. Biophys. Res. Commun. pmid:11162519
Wakugawa M et al. Evaluation of mite allergen-induced Th1 and Th2 cytokine secretion of peripheral blood mononuclear cells from atopic dermatitis patients: association between IL-13 and mite-specific IgE levels. 2001 J. Dermatol. Sci. pmid:11164708
Baran DA et al. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results. 2001 J. Heart Lung Transplant. pmid:11166613
Tanaka K et al. Immunosuppressive and non-immunosuppressive immunophilin ligands improve H(2)O(2)-induced cell damage by increasing glutathione levels in NG108-15 cells. 2001 Brain Res. pmid:11166708
Macleod MR et al. Serum withdrawal causes apoptosis in SHSY 5Y cells. 2001 Brain Res. pmid:11166724
Boulad F et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. 2000 Br. J. Haematol. pmid:11167755
Jørgensen PF et al. Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production. 2001 Scand. J. Immunol. pmid:11169223
Bayguinov O et al. Muscarinic stimulation increases basal Ca(2+) and inhibits spontaneous Ca(2+) transients in murine colonic myocytes. 2001 Am. J. Physiol., Cell Physiol. pmid:11171588
Manzarbeitia C et al. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients. 2001 Liver Transpl. pmid:11172391
Shibazaki Y et al. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats. 2001 Brain Res. pmid:11172783
Panhans-Gross A et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). 2001 J. Allergy Clin. Immunol. pmid:11174203
Hauk PJ and Leung DY Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? 2001 J. Allergy Clin. Immunol. pmid:11174211
Paller AS Use of nonsteroidal topical immunomodulators for the treatment of atopic dermatitis in the pediatric population. 2001 J. Pediatr. pmid:11174611
Hashimoto M et al. Feasibility of cryopreserved tracheal xenotransplants with the use of short-course immunosuppression. 2001 J. Thorac. Cardiovasc. Surg. pmid:11174729
Hunt SA New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus. 2000 May-Jun Cardiol Rev pmid:11174892
Frankel SJ and Kerdel FA Topical tacrolimus. 2001 Skin Therapy Lett. pmid:11176043
Schwetz BA From the Food and Drug Administration. 2001 JAMA pmid:11176890
Mancinelli LM et al. The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. 2001 Clin. Pharmacol. Ther. pmid:11180035
Lester LB et al. Targeted protein kinase A and PP-2B regulate insulin secretion through reversible phosphorylation. 2001 Endocrinology pmid:11181538
Duijnhoven EM et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. 2001 J. Am. Soc. Nephrol. pmid:11181807
O'hara M et al. Latent intracellular Epstein-Barr Virus DNA demonstrated in ocular posttransplant lymphoproliferative disorder mimicking granulomatous uveitis with iris nodules in a child. 2001 J AAPOS pmid:11182679
Lee RK and Wurtman RJ Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors. 2000 Ann. N. Y. Acad. Sci. pmid:11193162
Okabe H et al. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction. 2000 J. Pharm. Pharmacol. pmid:11197074
Tenney F and Sakarcan A Fatal cytomegalovirus disease in a high-risk renal transplant recipient. 2001 Pediatr. Nephrol. pmid:11198610
Pouteil-Noble C and Guebre F [Effect of immunosuppressants on lipids]. 2000 Nephrologie pmid:11200615
Odorico JS et al. Improved solitary pancreas transplant graft survival in the modern immunosuppressive era. 2000 Nov-Dec Cell Transplant pmid:11202579
Pou L et al. Mycophenolic acid plasma concentrations: influence of comedication. 2001 Ther Drug Monit pmid:11206040
Ierardi E et al. Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. 2001 Aliment. Pharmacol. Ther. pmid:11207512
Koshika T et al. Pretreatment with FK506 improves survival rate and gas exchange in canine model of acute lung injury. 2001 Am. J. Respir. Crit. Care Med. pmid:11208629
Wong PW et al. ortho-substituted PCB95 alters intracellular calcium signaling and causes cellular acidification in PC12 cells by an immunophilin-dependent mechanism. 2001 J. Neurochem. pmid:11208908
Bekersky I et al. Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. 2001 J Clin Pharmacol pmid:11210398
Leidig-Bruckner G et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. 2001 Lancet pmid:11210996
Kasahara M et al. Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. 2001 Transplantation pmid:11211185
Ohashi H and Ohno R [Immunodeficiency induced by immunosuppressive agents]. 2000 Ryoikibetsu Shokogun Shirizu pmid:11212769
Wang K et al. Transplantation of infantile bladder in rats: an alternative procedure for bladder augmentation. 2001 Transplantation pmid:11213059
Molleví DG et al. Heart and liver xenotransplantation under low-dose tacrolimus: graft survival after withdrawal of immunosuppression. 2001 Transplantation pmid:11213062
Paolillo JA et al. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. 2001 Transplantation pmid:11213069
Molmenti EP et al. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. 2001 Transplantation pmid:11213072
Pauli-Magnus C et al. Short-term efficacy of tacrolimus ointment in severe uremic pruritus. 2000 Nov-Dec Perit Dial Int pmid:11216583
Mahalati K and Kahan BD Pharmacological surrogates of allograft outcome. 2000 Ann. Transplant. pmid:11217202
Petering H et al. [Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506)]. 2001 Hautarzt pmid:11220239
van Mourik ID and Kelly DA Immunosuppressive drugs in paediatric liver transplantation. 2001 Paediatr Drugs pmid:11220404
Pyrzynska B et al. Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes. 2001 Neurochem. Int. pmid:11222921
Passerini P and Ponticelli C Treatment of focal segmental glomerulosclerosis. 2001 Curr. Opin. Nephrol. Hypertens. pmid:11224693
Feng FY et al. FK506 rescues peripheral nerve allografts in acute rejection. 2001 J. Neurotrauma pmid:11229713
Cruz MC et al. Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans. 2001 EMBO J. pmid:11230126
Pournaras CC et al. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506). 2001 J. Invest. Dermatol. pmid:11231333
Easing eczema. 2001 Health News pmid:11232120
Günther M et al. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. 2001 Transplantation pmid:11233913
García Sánchez MJ et al. Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy. 2001 Clin Pharmacokinet pmid:11236810
Riggins PS and Clipstone NA T cell activation signals upregulate CBP-dependent transcriptional activity. 2001 Biochem. Biophys. Res. Commun. pmid:11237736
Hassan-Walker AF et al. CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus. 2001 J. Infect. Dis. pmid:11237798
Armstrong VW and Oellerich M New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. 2001 Clin. Biochem. pmid:11239509
Reitamo S Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis. 2001 J. Allergy Clin. Immunol. pmid:11240943
Wollenberg A et al. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. 2001 J. Allergy Clin. Immunol. pmid:11240954
Yamamoto T and Nishioka K Topical tacrolimus is effective for facial lesions of psoriasis. 2000 Nov-Dec Acta Derm. Venereol. pmid:11243645
Leinwand LA Calcineurin inhibition and cardiac hypertrophy: a matter of balance. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11248009
Fox DS et al. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans. 2001 Mol. Microbiol. pmid:11251806
US FDA advisory committee recommends approval of tacrolimus ointment. 2000 Skin Therapy Lett. pmid:11252243
Strestíková P et al. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages. 2000 Physiol Res pmid:11252540
Fellermann K et al. [Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus]. 2001 Med. Klin. (Munich) pmid:11253280
Shimoyama M et al. [Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension]. 2001 J Cardiol pmid:11255695
Wang L et al. Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats. 2001 Ren Fail pmid:11256520